SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is generating buzz as its community anticipates the upcoming 4/20 cultural event, rallying around its mission to support global cannabis legalization and integrate real-world utility while proclaiming itself "like Bitcoin but way higher."

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending due to reaffirmed FY25 outlook and robust VEVYE script trends, bolstered by CVS Caremark Tier 1 formulary status. The community actively anticipates a potential short squeeze and accelerated growth, further fueled by a Deloitte audit upgrade signaling big-cap ambitions within the ophthalmic sector.

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

OPENAI CRYPTO is trending due to overwhelming community confusion and skepticism, with many users questioning its legitimacy as a potential scam and differentiating it from the actual OpenAI AI company.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X Shares

Direxion Daily Junior Gold Miners Index Bull 2X Shares

JNUG is surging as gold hits all-time highs, driven by accelerating global central bank gold accumulation and widespread concerns over U.S. debt, persistent inflation, and geopolitical uncertainty. The community is actively discussing the dollar's debasement and anticipating further gains from expected interest rate cuts and expanded monetary stimulus.

Bill Holdings, Inc. engages in the provision of cloud-based software solutions. The firm simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses. Its software helps customers generate and process invoices, streamline approvals, send and receive payments, sync with their accounting systems and manage their cash. The company was founded by Rene Lacertea in April 2006 and is headquartered in San Jose, CA.

BILL Holdings Inc

Bill.com Holdings Inc

BILL Holdings is surging on reports of potential acquisition talks with private equity firm Hellman & Friedman, which follows strong quarterly earnings and fuels widespread community speculation about a potential buyout price. Multiple activist investors are also pressuring the fintech company for strategic alternatives, driving investor interest and debate on its valuation.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

BeOne Medicines Ltd - ADR

BeiGene Ltd - ADR

BeOne Medicines ($ONC), formerly BeiGene, is trending as a global oncology leader following numerous analyst upgrades and significant pipeline advancements, including first-in-world approval for sonrotoclax in China and FDA approval for a new Brukinsa tablet formulation. The community is actively discussing the company's expanding U.S. manufacturing presence and strategic collaborations like the one with ImmunityBio as key drivers for future growth.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is drawing buzz following its recent Coinbase listing and the rollout of its Super App, which includes updated staking options. The community is actively accumulating, highlighting its ISO20022 and MiCA compliance for payment utility, often comparing its potential favorably against XRP as it approaches its final token unlocks.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is actively discussed following its recent Q3 earnings report, which highlighted a revenue beat and raised guidance but resulted in a puzzling stock dip, intensified by a prior FDA alert concerning certain product lots. The community views this as a significant undervaluation, with many anticipating a strong rebound driven by operational efficiencies, future catalysts, and persistent speculation of a potential takeover.

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers' enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

Nutanix Inc - Ordinary Shares - Class A

Nutanix Inc 

Nutanix is trending as the company announced a significant accelerated share repurchase program, signaling confidence and prompting a rebound after a recent downturn. The community is actively discussing whether this buyback, coupled with its strategic position in hybrid cloud and enterprise AI against competitors like Broadcom/VMware, can sustain a recovery from recent declines.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom Inc. is trending amid a mixed sentiment, as robust preliminary revenue and an AI-driven Stelo platform upgrade are overshadowed by ongoing community concerns regarding recent FDA Class 1 recalls for its G7 device, product reliability, and potential class-action lawsuits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Core Molding Technologies (CMT) Q3 Earnings and Revenues Miss Estimates

Core Molding Technologies (CMT) delivered earnings and revenue surprises of -45.00% and -16.95%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Proto Labs (PRLB) Tops Q3 Earnings and Revenue Estimates

Proto Labs (PRLB) delivered earnings and revenue surprises of +20.51% and +1.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Myers (MYE) Q3 Earnings and Revenues Beat Estimates

Myers (MYE) delivered earnings and revenue surprises of +4.00% and +3.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Core Molding Technologies (CMT) Surges 8.2%: Is This an Indication of Further Gains?

Core Molding Technologies (CMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Core Molding Technologies (CMT) Q2 Earnings and Revenues Beat Estimates

Core Molding Technologies (CMT) delivered earnings and revenue surprises of +2.17% and +5.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Proto Labs (PRLB) Q2 Earnings and Revenues Beat Estimates

Proto Labs (PRLB) delivered earnings and revenue surprises of +24.24% and +6.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for May 28th 

Core Molding Technologies, Inc. is an engineered materials company specializing in molded thermoplastic and thermoset structural products, principally in building products, utilities, transportation and powersports industries across North America. The company offers compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics and structural foam and structural web injection molding. The company was founded in 1996 and is headquartered in Columbus, OH.

Core Molding Technologies

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$20.45
Prev Close	$20.55
Open	$20.63
Dividend Yield	0.00%
50-Day Moving Average	$19.62
Beta	0.79
Avg. Volume	24,069.70
PE Ratio	22.01

52-Week High	$22.29
52-Week Low	$12.25
Market Capitalization	$253.16M
EPS (Annual)	$1.51
Price to Book	1.13
Revenue Per Employee	$192,597.45
Enterprise Value/EBITDA	N/A

CMT
Core Molding Technologies

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CMT News

CMTCore Molding Technologies